The American Board of Internal Medicine (ABIM) has launched Special Pathway E, a pilot program aimed at solving one of the biggest challenges faced by highly qualified international medical graduates (IMGs): achieving certification in internal medicine and sub-specialties without having to repeat a full U.S. residency.

This pathway provides an alternative certification route for individuals who have completed intensive medical training abroad and an ACGME-accredited fellowship in the United States. If successful, it can help address physician shortages in underserved areas while giving well-trained specialists the credentials they need to practice in the U.S.

1. Overview of ABIM Special Pathway E

Under Special Pathway E, certain physicians who completed residency training in internal medicine outside the U.S. or Canada and have completed an ACGME-accredited fellowship may apply for ABIM Internal Medicine Board Certification without needing to redo a full U.S. internal medicine residency.

Key points about the pilot program:

• Approved for at least five years; available now.
• Applies to all ABIM subspecialties where accredited fellowship training is required.
• Fellowship training length does not affect eligibility (can be one or more years, depending on subspecialty requirements).
• The program director must attest fellowship completion via ABIM’s FasTrack Clinical Competence Evaluation System.
• Must have a valid, unrestricted medical license in the U.S., its territories, or Canada.

2. Eligibility Requirements

To qualify, candidates must meet the following:

• International Residency Completion
• Three years of verified graduate medical education in internal medicine conducted abroad (outside the U.S. or Canada).

Exceptional Qualification Status

Either designated as “exceptionally qualified” according to the ACGME Common Program Requirements (Fellowship), III.A.1.c, or having entered fellowship after completing an ACGME-International (ACGME-I) residency.

“Exceptionally qualified” applicants typically demonstrate clinical excellence compared to peers, along with one or more of the following:

• Additional clinical or research training
• Scholarship in the specialty
• Leadership during or after training
• Completion of an ACGME-I-accredited residency abroad

Fellowship Completion

• Completed an ACGME-accredited fellowship in an ABIM subspecialty

3. How the Pilot Works

Application Process: Candidates submit a PDF application to establish eligibility for taking the ABIM Internal Medicine Certification Exam.

Timing: Application is possible only after fellowship completion and documentation of competency in all domains via FasTrack.

Retroactive Eligibility: Fellows who completed ACGME-accredited training in July 2016 or later are eligible to apply.

Board Eligibility Note: For subspecialty certification, candidates must first pass the ABIM Internal Medicine Certification Exam before applying for subspecialty board exams.

4. Why This Matters for International Medical Graduates

For decades, IMGs who entered U.S. fellowship programs after completing residency abroad faced a significant obstacle;

ABIM requirement: Candidates must have internal medicine board certification to be eligible for subspecialty exams.

Licensure barriers: In 26 U.S. states, permanent licensure requires three years of U.S. ACGME-accredited residency training, regardless of fellowship completion.

The result? Many IMGs, even after passing USMLE exams and completing highly competitive U.S. fellowships, cannot obtain full licensure or take subspecialty board exams without repeating U.S. residency — a costly, time-consuming, and often impossible task given the competitive match rates.

Special Pathway E is designed to eliminate unnecessary repetition for individuals who have already demonstrated their competence in fellowship training.

5. Example: Dr. JD’s Journey

Dr. JD, an IMG from Country X, completed an internal medicine residency abroad and secured a fellowship position in the USA as an “exceptionally qualified” candidate.

They excelled in her program but realized that without U.S. board certification in internal medicine, they couldn’t sit for the subspecialty board exam—and licensure restrictions in half the states would limit their practice options to temporary or supervised roles.

Previously, Dr. JD’s only option was to redo the entire U.S. internal medicine residency. Now, through ABIM Special Pathway E, they can apply directly for the internal medicine board exam after completing their fellowship, potentially skipping those years of repeated training.

Conclusion

ABIM Special Pathway E represents a significant shift in certification policy — one that bridges longstanding gaps for “exceptionally qualified” international medical graduates.

By recognizing the value of high-level fellowship training and international residency, ABIM’s program could ease some of the bottlenecks that have hindered talented IMGs from fully contributing to U.S. healthcare.

In short: Special Pathway E could help transform fellowship from a dead-end for some IMGs into a viable, respected route to board certification — benefiting physicians, patients, and health systems alike.

Author: Tahsin Ozpolat, MD

Tahsin Ozpolat graduated from Istanbul Faculty of Medicine and completed his internal medicine residency in same institution. He completed his nephrology fellowship at the University of Arizona and currently, he works as a hematology fellow at the University of Washington. He is interested in translational and clinical research.

Resources

1) https://www.abim.org/certification/policies/candidates-for-special-consideration/
2) https://www.abim.org/about/faqs/#pilot-pathway
3) https://www.kidneynews.org/view/journals/kidney-news/15/2/article-p1_2.xml